Elizabeth Attias

Elizabeth Attias

Company: Sermonix Pharmaceuticals

Job title: Chief Strategy and Development Officer


Panel Discussion: Understanding the Promises, Implementation Issues & Future Challenges for Liquid Biopsy Clinical Applications 1:30 pm

Uncovering progresses and challenges in payor policy for liquid biopsy reimbursement Mobilizing resources to support the commercialisation of ctDNA testing through improving payor coverage policies Expanding innovative collaborations to advocate liquid biopsy as a promising tool for routine molecular analysis and improve commercialization and coverageRead more

day: Day Two Track B PM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.